Gordon Moe

Research Programs

Cardiovascular Disease & Diabetes Research Program

Recent Publications

1. Lee, C, Chow, CM, Yan, AT, Moe, GW, Tu, JV, Chu, JY et al.. Awareness of Warning Symptoms of Heart Disease and Stroke: Results of a Follow-up Study of the Chinese Canadian Cardiovascular Health Project. CJC Open. 2021;3 (6):741-750. doi: 10.1016/j.cjco.2021.01.014. PubMed PMID:34169253 PubMed Central PMC8209403.
2. Chu, JY, Kaliwal, Y, Koh, M, Chen, R, Chow, CM, Ko, DT et al.. COVID-19 AND ITS CARDIAC AND NEUROLOGICAL COMPLICATIONS AMONG ONTARIO VISIBLE MINORITIES. Can J Neurol Sci. 2021; :1-29. doi: 10.1017/cjn.2021.148. PubMed PMID:34162448 .
3. Fuery, MA, Chouairi, F, Januzzi, JL, Moe, GW, Caraballo, C, McCullough, M et al.. Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure. JACC Heart Fail. 2021;9 (7):497-505. doi: 10.1016/j.jchf.2021.02.011. PubMed PMID:33992564 .
4. McDonald, M, Virani, S, Chan, M, Ducharme, A, Ezekowitz, JA, Giannetti, N et al.. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction. Can J Cardiol. 2021;37 (4):531-546. doi: 10.1016/j.cjca.2021.01.017. PubMed PMID:33827756 .
5. Writing Group, Virani, SA, Zieroth, S, Bray, S, Ducharme, A, Harkness, K et al.. The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey. CJC Open. 2020;2 (3):151-160. doi: 10.1016/j.cjco.2020.03.001. PubMed PMID:32462129 PubMed Central PMC7242502.
6. Rabi, DM, McBrien, KA, Sapir-Pichhadze, R, Nakhla, M, Ahmed, SB, Dumanski, SM et al.. Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2020;36 (5):596-624. doi: 10.1016/j.cjca.2020.02.086. PubMed PMID:32389335 .
7. O'Meara, E, McDonald, M, Chan, M, Ducharme, A, Ezekowitz, JA, Giannetti, N et al.. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. Can J Cardiol. 2020;36 (2):159-169. doi: 10.1016/j.cjca.2019.11.036. PubMed PMID:32036861 .
8. Nerenberg, KA, Zarnke, KB, Leung, AA, Dasgupta, K, Butalia, S, McBrien, K et al.. Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2018;34 (5):506-525. doi: 10.1016/j.cjca.2018.02.022. PubMed PMID:29731013 .
9. Ezekowitz, JA, O'Meara, E, McDonald, MA, Abrams, H, Chan, M, Ducharme, A et al.. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Can J Cardiol. 2017;33 (11):1342-1433. doi: 10.1016/j.cjca.2017.08.022. PubMed PMID:29111106 .
10. Leung, AA, Daskalopoulou, SS, Dasgupta, K, McBrien, K, Butalia, S, Zarnke, KB et al.. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Can J Cardiol. 2017;33 (5):557-576. doi: 10.1016/j.cjca.2017.03.005. PubMed PMID:28449828 .